Same Indication

Ipilimumab vs Losartan

Ipilimumab vs Losartan: Overview

This comparison examines the pharmacological differences between Ipilimumab and Losartan.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Losartan: Angiotensin II receptor type 1 antagonist.

Pharmacokinetics

Half-life: Ipilimumab β€” 14.7 days; Losartan β€” 2 hours.

Chemical Properties

Molecular Formula: Losartan β€” C22H23ClN6O.

Molecular Weight: Losartan β€” 422.9200 g/mol.

Type: Ipilimumab β€” Antibody; Losartan β€” Small molecule.